Reviewing Escalon Medical (OTCMKTS:ESMC) & InMode (OTCMKTS:INMD)

Escalon Medical (OTCMKTS:ESMC) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk.

Analyst Ratings

This is a breakdown of recent ratings for Escalon Medical and InMode, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Escalon Medical 0 0 0 0 N/A
InMode 0 0 4 0 3.00

InMode has a consensus price target of $37.00, suggesting a potential downside of 17.87%. Given InMode’s higher possible upside, analysts plainly believe InMode is more favorable than Escalon Medical.

Earnings & Valuation

This table compares Escalon Medical and InMode’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Escalon Medical $9.63 million 0.12 -$250,000.00 N/A N/A
InMode $100.16 million 14.38 $22.37 million N/A N/A

InMode has higher revenue and earnings than Escalon Medical.

Profitability

This table compares Escalon Medical and InMode’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Escalon Medical 4.19% 24.25% 7.50%
InMode 30.33% 50.50% 36.58%

Insider & Institutional Ownership

11.7% of InMode shares are owned by institutional investors. 1.9% of Escalon Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

InMode beats Escalon Medical on 9 of the 10 factors compared between the two stocks.

About Escalon Medical

Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is based in Wayne, Pennsylvania.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. InMode Ltd. offers its products directly in the United States, Canada, the United Kingdom, Spain, and India, as well as indirectly through third-party distributors internationally. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.

Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.